Gary John Schiller

机构：APLA Health, University of California, Los Angeles · ORCID：0000-0002-7508-3467

发表论文 736 篇 · 总被引 23662 次 · h-index 73

代表论文

• Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm (2026 · Journal of Clinical Oncology · 被引 8)
• Ziftomenib in combination with venetoclax and azacitidine in relapsed/refractory NPM1-m or KMT2A-r acute myeloid leukemia: Updated phase 1a/b safety and clinical activity results from KOMET-007 (2025 · Blood · 被引 8)
• Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax: a multinational retrospective cohort study (2025 · Blood · 被引 7)
• RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT (2025 · Blood · 被引 6)
• Preliminary anti-leukemia activity from A phase 1 study of cln-049, a novel anti-FLT3 x anti-CD3 bispecific T-cell engager, in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS) (2025 · Blood · 被引 3)
• Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 3)